1. Home
  2. SABS vs NWGL Comparison

SABS vs NWGL Comparison

Compare SABS & NWGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • NWGL
  • Stock Information
  • Founded
  • SABS 2014
  • NWGL 2008
  • Country
  • SABS United States
  • NWGL Macau
  • Employees
  • SABS N/A
  • NWGL N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • NWGL
  • Sector
  • SABS Health Care
  • NWGL
  • Exchange
  • SABS Nasdaq
  • NWGL Nasdaq
  • Market Cap
  • SABS 19.0M
  • NWGL 21.2M
  • IPO Year
  • SABS N/A
  • NWGL 2023
  • Fundamental
  • Price
  • SABS $1.20
  • NWGL $1.31
  • Analyst Decision
  • SABS Strong Buy
  • NWGL
  • Analyst Count
  • SABS 5
  • NWGL 0
  • Target Price
  • SABS $12.40
  • NWGL N/A
  • AVG Volume (30 Days)
  • SABS 36.5K
  • NWGL 136.6K
  • Earning Date
  • SABS 05-19-2025
  • NWGL 05-21-2025
  • Dividend Yield
  • SABS N/A
  • NWGL N/A
  • EPS Growth
  • SABS N/A
  • NWGL N/A
  • EPS
  • SABS N/A
  • NWGL N/A
  • Revenue
  • SABS $1,512,723.00
  • NWGL $21,707,613.00
  • Revenue This Year
  • SABS N/A
  • NWGL N/A
  • Revenue Next Year
  • SABS N/A
  • NWGL N/A
  • P/E Ratio
  • SABS N/A
  • NWGL N/A
  • Revenue Growth
  • SABS N/A
  • NWGL N/A
  • 52 Week Low
  • SABS $1.36
  • NWGL $1.04
  • 52 Week High
  • SABS $5.01
  • NWGL $17.21
  • Technical
  • Relative Strength Index (RSI)
  • SABS 33.63
  • NWGL 47.64
  • Support Level
  • SABS $1.53
  • NWGL $1.15
  • Resistance Level
  • SABS $1.80
  • NWGL $1.43
  • Average True Range (ATR)
  • SABS 0.15
  • NWGL 0.15
  • MACD
  • SABS 0.02
  • NWGL -0.02
  • Stochastic Oscillator
  • SABS 0.00
  • NWGL 31.43

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

Share on Social Networks: